A Retrospective Cohort Study Using Health Administrative Claims Databases to Assess Adverse Pregnancy and Infant Outcomes in Women with Psoriasis Who Were Exposed to Guselkumab Versus Other Biologic Therapies During Pregnancy. PASS-EMA First published 08/08/2019 Last updated 12/01/2026 EU PAS number:EUPAS30740 Study Ongoing